Evidence map›Paper›PMID 31210817›Full record

ArticleOpen access Macedonian journal of medical sciences2019

Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark.

Nikola Hristov Mumdzhiev, Daniela Valerieva Radicheva, Mariana Penkova Radicheva, Rumen Valchev Tenev, Zlatina Dimitrova Vasileva

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Linked Intronic Polymorphisms of theInternational journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nikola Hristov MumdzhievUMHAT Prof. Stojan Kirkovitch, Stara Zagora, Bulgaria.
Daniela Valerieva RadichevaUMHAT Prof. Stojan Kirkovitch, Stara Zagora, Bulgaria.
Mariana Penkova RadichevaUMHAT Prof. Stojan Kirkovitch, Stara Zagora, Bulgaria.
Rumen Valchev TenevUMHAT Prof. Stojan Kirkovitch, Stara Zagora, Bulgaria.
Zlatina Dimitrova VasilevaUMHAT Prof. Stojan Kirkovitch, Stara Zagora, Bulgaria.
Trakia University · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C is the second leading cause of liver cirrhosis and hepatocellular carcinoma. Although the discovery of direct-acting agents made the disease curable, HCV elimination can be achieved solely by the host's immunologic arsenal. CASE REPORT: We report the case of a 29-year-old woman with chronic hepatitis C infection - elevated transaminases, positive serology. HCV was detectable on two occasions, and histology showed mild disease - A1F1. Upon follow up and without any treatment, the patient achieved spontaneous clearance confirmed by two consecutive undetectable HCV RNA tests. Spontaneous HCV clearance rarely occurs - 0.5% per person-year. This is sometimes accompanied by special circumstances like additional disease or medical interventions. Host factors like gender and interleukin-28B polymorphisms have been known to contribute to clearance. Viral factors like HCV RNA levels are also a factor. The characteristics of host-viral interplay - age of acquisition and fibrosis stage - cannot be overlooked.

conclusionAll of the abovementioned factors contribute to the complex immunological interaction between virus and host and the result, although rarely can be spontaneous clearance.

Indexed as

Hepatitis Cinterferon free treatmentspontaneous clearance

Identifiers

PMID31210817
PMCPMC6560286
OpenAlexW2947114945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.